Pharmaco-Kinesis Corporation (PKC) announced today that it will develop innovative cloud-linked biosensors in partnership with the Ohio Clinical Trials Collaborative (OCTC) of Ohio. This undertaking seeks to transform medical practice away from reactive medicine to proactive prevention through real time, continuous cloud-linked monitoring driven by PKC's innovative SMART (Simultaneous Multiplexed Automated Real Time Telemedicine) platform.
Transparency Market Research announces the release of a report titled “Biosensors Market (Technologies: Electrochemical, Optical, Thermal, Piezoelectric; Applications: Medical, Food Toxicity Detection, Industrial Process Control, Agriculture, Environment and Others; and End Users: Point of Care Testing, Home Healthcare Diagnostics, Research Laboratories, Security and Bio-defense, and Food Industry) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”.
Pharmaco-Kinesis Corporation (PKC) and the Ohio Clinical Trials Collaborative (OCTC) today announced that they have agreed to explore the potential of a partnership aimed at the development of technology that provides physicians real-time patient information that once required days to secure.
Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.
Cypress Semiconductor Corp. today announced it has joined the Fast IDentity Online (FIDO) Alliance, an industry consortium revolutionizing online authentication with standards-based specifications. Cypress is designing its upcoming fingerprint reader solution to meet FIDO standards.
FotoNation Limited, a wholly owned subsidiary of Tessera Technologies, Inc. and the leading provider of computational imaging solutions for smartphones and digital still cameras, today announced its acquisition of Smart Sensors Limited (“SSL”), an award winning developer of iris recognition biometric technology, a transaction that closed in the fourth quarter of 2014.
Research and Markets has announced the addition of the "Biosensors Market by Application, Product, Technology & Geography - Analysis & Forecast to 2020" report to their offering.
Biosensors International has announced completion of patient enrollment in LEADERS Free Japan, a revolutionary trial involving BioFreedom™, the company's novel polymer and carrier-free drug-coated stent (DCS).
Valencell, a leader in performance biometric data sensor technology, today announced it has been granted an additional eight patents by the United States Patent and Trademark Office. The new patents are critical to the accurate monitoring and tracking of biometrics across a variety of form-factors, such as earbuds, wristbands, armbands, and jewelry, and bring the Company’s total number of granted patents to more than 20, with dozens of additional patents pending.
University of Groningen scientists have developed a molecular sensor to measure 'crowding' in cells, which reflects the concentration of macromolecules present. The sensor provides quantitative information on the concentration of macromolecules in bacteria and in mammalian cells. A description of the sensor and its validation was published in Nature Methods on 2 February.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.